Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Waes, J. Segers, J. Egmond, L. Nimmen, F. Barbier, R. Wieme, L. Demeulenaere (1974)
Chronic Liver Disease and Hepatitis-B Antigen: A Prospective StudyBritish Medical Journal, 3
J. Boyer (1976)
Chronic hepatitis--a perspective on classification and determinants of prognosis.Gastroenterology, 70 6
Hadziyannis Sj (1974)
Chronic viral hepatitis.Clinics in gastroenterology, 3 2
C. Burrell, E. Gowans, R. Rowland, P. Hall, A. Jilbert, B. Marmion (1984)
Correlation Between Liver Histology and Markers of Hepatitis B Virus Replication in Infected Patients: A Study by In Situ HybridizationHepatology, 4
Alverti Alverti, Tremolada Tremolada, Fattovich Fattovich (1983)
Virus replication and liver disease in chronic hepatitis B virus infectionDig Dis Sci, 28
G. Davis, J. Hoofnagle, J. Waggoner (1984)
Spontaneous reactivation of chronic hepatitis B virus infection.Gastroenterology, 86 2
S. Schalm, W. Summerskill, G. Gitnick, L. Elveback (1976)
Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.Gut, 17
Core-antigen specific im-1983
K. Lo, M. Tong, M. Chien, Y. Tsai, Y. Liaw, K.-C. Yang, H. Chian, H. Lin, S. Lee (1982)
The natural course of hepatitis B surface antigen-positive chronic active hepatitis in Taiwan.The Journal of infectious diseases, 146 2
I. Weller, M. Fowler, J. Monjardino, H. Thomas (1982)
The detection of hbv‐dna in serum by molecular hybridisation: A more sensitive method for the detection of complete hbv particlesJournal of Medical Virology, 9
Huang Sn, Neurath Ar (1979)
Immunohistologic demonstration of hepatitis B viral antigens in liver with reference to its significance in liver injury.Laboratory Investigation, 40
Jorge Rakela, Allan Redeker, Berta Weliky (1983)
Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis.Gastroenterology, 84 5 Pt 1
Nair Nair, Tong Tong, Stevenson Stevenson (1985)
Effects of short term high dose prednisone therapy in patients with chronic active hepatitis B virus infectionLiver, 5
Hepatitis B virus infection and primary hepatocellular carcinoma : epidemiological , clinical , and virological studies in Senegal from the perspective of prevention by active immunization
S. Hadziyannis, H. Lieberman, Gerassimos Karvountzis, D. Shafritz (2007)
Analysis of Liver Disease, Nuclear HBcAg, Viral Replication, and Hepatitis B Virus DNA in Liver and Serum of HBcAg Vs. Anti‐HBe Positive Carriers of Hepatitis B VirusHepatology, 3
J. Groote, J. Fevery, L. Lepoutre, Ziekenhuis St-Raphael, Belgium Leuven (1978)
Long-term follow-up of chronic active hepatitis of moderate severity.Gut, 19
Realdi (1980)
10.1016/0016-5085(80)90130-4Gastroenterology, 79
Mai-Ching Chien, Myron Tong, Kwang-Juei Lo, Jaw-Kuang Lee, David Millch, Girish Vyas, Bert Murphy (1981)
Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.Journal of the National Cancer Institute, 66 3
G. Levy, H. Helin, T. Edgington (1984)
The Pathobiology of Viral Hepatitis and Immunologic Activation of the Coagulation Protease NetworkSeminars in Liver Disease, 4
Y. Liaw, C. Chu, I. Su, Miau-ju Huang, D. Lin, C. Changchien (1983)
Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis.Gastroenterology, 84 2
O. Yokosuka, M. Omata, F. Imazeki, K. Hirota, J. Mori, K. Uchiumi, Y. Ito, K. Okuda (1985)
Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study.Gastroenterology, 89 2
Immunohistologic demonstration of hep-1986
M. Berninger, Marlene Hammer, B. Hoyer, J. Gerin (1982)
An assay for the detection of the dna genome of hepatitis b virus in serumJournal of Medical Virology, 9
G. Realdi, A. Alberti, M. Rugge, F. Bortolotti, A. Rigoli, F. Tremolada, A. Ruol (1980)
Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection.Gastroenterology, 79 2
L. Silva, E. Mattar, F. Carrilho, A. Takeda, H. Júnior, L. Gayotto (1983)
Disappearance of hepatitis B surface antigen in chronic type B hepatitis after clinical and laboratorial relapse produced by abrupt withdrawal of immunosuppressive drugs.Revista do Instituto de Medicina Tropical de Sao Paulo, 25 6
A. Kipps, D.J.M Mackenzie, W. Naudé, R. Mcdonald (1973)
S.S.P.E. AND SALK VACCINEThe Lancet, 302
Hadziyannis (1974)
10.1016/S0300-5089(21)00376-XClin Gastroenterol, 3
J. Hoofnagle, G. Dusheiko, L. Seeff, E. Jones, J. Waggoner, Z. Bales (1981)
Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis.Annals of internal medicine, 94 6
A. Trevisan, G. Realdi, A. Alberti, F. Noventa (1979)
Relationship between membrane-bound immunoglobulin and viral antigens in liver cells from patients with hepatitis B virus infection.Gastroenterology, 77 2
S. Huang, A. Neurath (1979)
Immunohistologic demonstration of hepatitis B viral antigens in liver with reference to its significance in liver injury.Laboratory investigation; a journal of technical methods and pathology, 40 1
Alverti (1983)
10.1007/BF01311722Dig Dis Sci, 28
A. Alberti, P. Pontisso, G. Realdi (1981)
Changes in hepatitis B virus DNA‐polymerase activity in patients with chronic infectionJournal of Medical Virology, 8
P. Coursaget, P. Maupas, A. Goudeau, J. Chiron, J. Drucker, F. Denis, I. Diop‐Mar (1980)
Primary hepatocellular carcinoma in intertropical Africa: relationship between age and hepatitis B virus etiology.Journal of the National Cancer Institute, 65 4
I. Sheen, Y. Liaw, D. Tai, C. Chu (1985)
Hepatic decompensation associated with hepatitis B e antigen clearance in chronic type B hepatitis.Gastroenterology, 89 4
Baruch Blumberg, Bernard Larouzé, W. London, Barbara Werner, Jana Hesser, I. Millman, Gerard Saimot, Maurice Payet (1975)
The relation of infection with the hepatitis B agent to primary hepatic carcinoma.The American journal of pathology, 81 3
N. Naumov, M. Mondelli, G. Alexander, R. Tedder, A. Eddleston, R. Williams (1984)
Relationship Between Expression of Hepatitis B Virus Antigens in Isolated Hepatocytes and Autologous Lymphocyte Cytotoxicity in Patients with Chronic Hepatitis B Virus InfectionHepatology, 4
M. Tong, S. Sun, B. Schaeffer, N. Chang, K. Lo, R. Peters (1971)
Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan.Annals of internal medicine, 75 5
M. Mondelli, G. Vergani, A. Alberti, D. Vergani, B. Portmann, A. Eddleston, R. Williams (1982)
Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes.Journal of immunology, 129 6
P. Nair, M. Tong, D. Stevenson, D. Roskamp, C. Boone (2008)
Effects of short-term, high-dose prednisone treatment of patients with HBsAg-positive chronic active hepatitis.Liver, 5 1
F. Bonino, F. Rosina, M. Rizzetto, R. Rizzi, E. Chiaberge, R. Tardanico, F. Callea, G. Verme (1986)
Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.Gastroenterology, 90 5 Pt 1
M. Nowicki, M. Tong, P. Nair, D. Stevenson (1984)
Detection of Anti‐HBc IgM Following Prednisone Treatment in Patients with Chronic Active Hepatitis B Virus InfectionHepatology, 4
A. Trevisan, G. Realdi, A. Alberti, G. Ongaro, E. Pornaro, R. Meliconi (1982)
Core antigen-specific immunoglobulin G bound to the liver cell membrane in chronic hepatitis BGastroenterology, 82
K. Lam, Ching‐lung Lai, R. Ng, C. Trépo, P. Wu (1981)
Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis.The New England journal of medicine, 304 7
F. Dudley, P. Scheuer, S. Sherlock (1972)
Natural history of hepatitis-associated antigen-positive chronic liver disease.Lancet, 2 7792
M. Essex, G. Todaro, H. Hausen (1980)
Viruses in naturally occurring cancers. Book A, Book B.
R. Perrillo, C. Campbell, G. Sanders, F. Regenstein, C. Bodicky (1984)
Spontaneous clearance and reactivation of hepatitis B virus infection among male homosexuals with chronic type B hepatitis.Annals of internal medicine, 100 1
G. Scullard, Coleman Smith, T. Merigan, W. Robinson, P. Gregory (1981)
Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.Gastroenterology, 81 6
We investigated the efficacy of a short course of prednisone therapy in 20 patients with histologic evidence of chronic active hepatitis B. Sixteen of 20 prednisone‐treated patients who were initially serum hepatitis B virus DNA‐positive had a transient elevation of their serum ALT activity on withdrawal of prednisone. Subsequently, 14 of these 16 patients (87.5%) became persistently negative for serum hepatitis B virus DNA, and 10 also lost their HBeAg. In addition, there was a significant fall in serum ALT levels and HBsAg titers up to 12 months of follow‐up in the prednisone‐treated group. Five of 20 (25%) prednisone‐treated patients experienced a transient episode of hepatic decompensation coinciding with the peak of enzyme elevation. To contrast, only 3 of 15 (20%) initially hepatitis B virus DNA‐positive matched untreated patients followed during the same time period became negative for serum hepatitis B virus DNA, and no significant changes in serum ALT values or HBsAg titers were noted over the 12‐month study period. Thus, patients with chronic active hepatitis B appear to be responsive to immunologic manipulation with prednisone as indicated by a pronounced rebound immune response and clearance of hepatitis B virus DNA with improvement in liver disease activity.
Hepatology – Wolters Kluwer Health
Published: Nov 1, 1986
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.